Cobertura y asociación con variables clínicas de la vacunación antineumocócica en la población mayor de 65 años de Tarragona-Valls
Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Ministerio de Sanidad
2005
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866583571344392192 |
|---|---|
| author | Olga Ochoa Gondar |
| author_facet | Olga Ochoa Gondar |
| contents | Cobertura y asociación con variables clínicas de la vacunación antineumocócica en la población mayor de 65 años de Tarragona-Valls Olga Ochoa Gondar Jordi Bladé Creixenti Laura Palacios Llamazares Cruz María Fuentes Bellido Ángel Vila Córcoles Xabier Ansa Echeverría Salud Pneumococcal vaccines Immunizations Coverage Elderly Community acquired infection Background: In Catalonia, a polyanccharide pneumococcalvaccine (PPV) programme which includes subjects over 65 yearsold, was started in 1999. Three years later, we study the vaccinecover in relation to the presence of risk factors for pneumonia.Methods: Cross-sectional observational study conducted in 8Basic Health Areas (BHA) of Tarragona. All the subjects over 65years old and assigned to one of the 8 basic health areas participatingin the study were included (n= 11241). Using computerized clinicalrecords and vaccination records we evaluated whether each patienthad received PPV before January 2002, and the presence of diseaseor risk factors for pneumonia.Results: Global vaccination coverage was 44.4% (37.1% in 65-74 years, 53.9% in 75-84 and 51.5% in 85-99 years). The greatestcoverage was recorded in subjects with active neoplasm (56.7%),chronic necropathy (55.3%), chronic lung disease (54.2%) and chroniccardiopathy (53.5%). The least coverage was recorded in smokers(38.9%), alcoholic patients (43.6%) and chronic liver disease(46.5%). AVP coverage was 38.9% (CI 95%: 37.6-40.2) in subjectswithout any risk factors, 47.7% (CI 95%: 46.1-49.4) in those withone factor, and 52.7% (CI 95%:52.6-54.8) in those with two or morefactors. 2005 artículo científico 1135-5727 https://www.redalyc.org/articulo.oa?id=17079604 en http://www.redalyc.org/revista.oa?id=170 Revista Española de Salud Pública application/pdf Ministerio de Sanidad Revista Española de Salud Pública (España) Num.6 Vol.79 |
| format | Artículo científico |
| id | redalyc_17079604 |
| language | en |
| publishDate | 2005 |
| publisher | Ministerio de Sanidad |
| spellingShingle | Cobertura y asociación con variables clínicas de la vacunación antineumocócica en la población mayor de 65 años de Tarragona-Valls Olga Ochoa Gondar Salud Pneumococcal vaccines Immunizations Coverage Elderly Community acquired infection Cobertura y asociación con variables clínicas de la vacunación antineumocócica en la población mayor de 65 años de Tarragona-Valls Olga Ochoa Gondar Jordi Bladé Creixenti Laura Palacios Llamazares Cruz María Fuentes Bellido Ángel Vila Córcoles Xabier Ansa Echeverría Salud Pneumococcal vaccines Immunizations Coverage Elderly Community acquired infection Background: In Catalonia, a polyanccharide pneumococcalvaccine (PPV) programme which includes subjects over 65 yearsold, was started in 1999. Three years later, we study the vaccinecover in relation to the presence of risk factors for pneumonia.Methods: Cross-sectional observational study conducted in 8Basic Health Areas (BHA) of Tarragona. All the subjects over 65years old and assigned to one of the 8 basic health areas participatingin the study were included (n= 11241). Using computerized clinicalrecords and vaccination records we evaluated whether each patienthad received PPV before January 2002, and the presence of diseaseor risk factors for pneumonia.Results: Global vaccination coverage was 44.4% (37.1% in 65-74 years, 53.9% in 75-84 and 51.5% in 85-99 years). The greatestcoverage was recorded in subjects with active neoplasm (56.7%),chronic necropathy (55.3%), chronic lung disease (54.2%) and chroniccardiopathy (53.5%). The least coverage was recorded in smokers(38.9%), alcoholic patients (43.6%) and chronic liver disease(46.5%). AVP coverage was 38.9% (CI 95%: 37.6-40.2) in subjectswithout any risk factors, 47.7% (CI 95%: 46.1-49.4) in those withone factor, and 52.7% (CI 95%:52.6-54.8) in those with two or morefactors. 2005 artículo científico 1135-5727 https://www.redalyc.org/articulo.oa?id=17079604 en http://www.redalyc.org/revista.oa?id=170 Revista Española de Salud Pública application/pdf Ministerio de Sanidad Revista Española de Salud Pública (España) Num.6 Vol.79 |
| title | Cobertura y asociación con variables clínicas de la vacunación antineumocócica en la población mayor de 65 años de Tarragona-Valls |
| topic | Salud Pneumococcal vaccines Immunizations Coverage Elderly Community acquired infection |
| url | https://www.redalyc.org/articulo.oa?id=17079604 |